This House Resolution expresses support for designating the week of May 3-9, 2026, as "Tardive Dyskinesia Awareness Week" to educate the public and medical community about this involuntary movement disorder. Tardive dyskinesia (TD) is characterized by uncontrollable, repetitive movements and is often linked to prolonged use of certain medications for mental or gastrointestinal conditions. The resolution highlights that TD affects approximately 600,000 people in the U.S., with many remaining undiagnosed, and emphasizes that even mild symptoms can significantly impact individuals' lives. It stresses the importance of regular screening by healthcare providers and notes the availability of FDA-approved treatments. By supporting this awareness week, the House aims to encourage individuals across the United States to become better informed about tardive dyskinesia, promoting earlier recognition and treatment.